Assessment of combined α-GAL enzyme activity and lyso-GL3 for Fabry disease screening in women with chronic kidney disease.
Silva CAB, de Carvalho Barreto F, Neto OMV, Lucca LJ, Vieira FA, Gueiros APS, Boger MV, Silva AQ, Guedes FL, Israel KCP, Gordon GEM, Veloso VSP, Sevignani G, Barretto CT, Rosa MG, Pascotto RC, Ennes GS, da Silva Montenegro Malaguti Souza EM, Ribeiro MG, de Andrade LGM.
Silva CAB, et al. Among authors: boger mv.
Mol Genet Metab. 2024 Sep-Oct;143(1-2):108565. doi: 10.1016/j.ymgme.2024.108565. Epub 2024 Aug 16.
Mol Genet Metab. 2024.
PMID: 39182416
Free article.